• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Rigel Pharmaceuticals Inc

+ Add to Watchlist

RIGL:US

3.2050 USD 0.1150 3.46%

As of 10:31:07 ET on 07/28/2014.

Company Profile for Rigel Pharmaceuticals Inc (RIGL)

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. The Company's research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms.

Contact Information

Rigel Pharmaceuticals Inc

1180 Veterans Boulevard
South San Francisco, CA 94080
United States
Phone: 1-650-624-1100
Fax: 1-650-624-1101

Key Executives for Rigel Pharmaceuticals Inc (RIGL)

James M GowerChairman/CEORaul R RodriguezPresident/COO
Ryan D MaynardExec VP/CFOElliott B GrossbardExec VP/Chief Medical Officer
Donald G PayanExec VP/Pres:DiscoveryDolly A VanceExec VP:Affairs/Secy/Gen Cnsl

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil